Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
-
-
-
Apr 15, 2013 Drugs effective against tumors, studies show Tags: aacr 2013, bind-014, daniel von hoff, scottsdale healthcare, tgen
TGen and TD2 help Critical Outcome Technologies to present data at US Oncology summit
Tags: cancer, tgen[Source: TGen] - Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) is pleased to announce that it has accepted an invitation from US Oncology to present at the US Oncology Translational Oncology Program (TOP) Science Summit in Houston, Texas, on March 27, 2010.
The TOP science summit is a collaborative forum of scientific and academic thought leaders in early phase oncology research who assemble at this annual event to discuss new trends in oncology drug development and learn about promising investigational cancer compounds entering development.
For more information: TGen and TD2 help Critical Outcome Technologies to present data about COTI-2 at US Oncology summit in Texas
Quick Links
![]()
“A Bridge Crossed,” a brochure featuring the 2012 progress of Arizona’s Bioscience Roadmap, as well as "Performance Assessment 2002-12," featuring the latest bioscience sector data from Battelle Technology Partnership Practice, are now available.


Share on Twitter
Share on Facebook


